Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Daiichi Sankyo
Cipla
Fish and Richardson
QuintilesIMS

Generated: August 19, 2019

DrugPatentWatch Database Preview

Litigation Details for SANDOZ, INC. v. DUKE UNIVERSITY (M.D.N.C. 2017)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

SANDOZ, INC. v. DUKE UNIVERSITY (M.D.N.C. 2017)

Docket   Try a Free Trial Date Filed 2017-09-14
Court District Court, M.D. North Carolina Date Terminated 2018-04-24
Cause 28:2201 Declaratory Judgment Assigned To Catherine Caldwell Eagles
Jury Demand Plaintiff Referred To L. Patrick Auld
Parties ALCON LABORATORIES, INC.; ALLERGAN SALES, LLC; ALLERGAN, INC.; DUKE UNIVERSITY; SANDOZ, INC.
Patents 7,351,404; 7,388,029; 7,851,504; 8,038,988; 8,101,161; 8,263,054; 8,278,353; 8,299,118; 8,309,605; 8,338,479; 8,524,777; 8,586,630; 8,772,338; 8,906,962; 8,926,953; 8,933,120; 8,933,127; 9,155,716; 9,241,918; 9,579,270
Attorneys DAVID MATTHEW WILKERSON; ELIZABETH M. FLANAGAN; F. HILL ALLEN , IV; JONATHAN E. SINGER; LARRY STEPHEN MCDEVITT; ROBERT F. KAPPERS; THOMAS J. FILARSKI
Firms Fish & Richardson P.C.; Steptoe & Johnson LLP; Tharrington Smith, LLP; Van Winkle Buck Wall Starnes & Davis, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in SANDOZ, INC. v. DUKE UNIVERSITY
The small molecule drugs covered by the patents cited in this case are   Try a Free Trial and   Try a Free Trial .

Details for SANDOZ, INC. v. DUKE UNIVERSITY (M.D.N.C. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-09-14 1 infringed U.S. Patent Nos. 7,388,029 (the “’029 patent”) and 7,351,404 (the “’404 patent”). Allergan, …that a new patent number is involved (United States Patent No. 9,579,270 (“the ’270 patent)) and that…infringed U.S. Patent Nos. 8,038,988 (the “’988 patent”), 8,101,161 (the “’161 patent”), and 8,263,054…infringed U.S. Patent Nos. 8,906,962 (the “’962 patent”) and 8,926,953 (the “’953 patent). Allergan, Inc…certain Duke patents, including the ’270 patent asserted in this case as well as the ’029 patent asserted External link to document
2018-04-24 55 and issues of whether United States Patent 9,579,270 (the ’270 patent) is invalid, unenforceable, or infringed…previously presided over cases that address related patents. This Court’s familiarity with the technical subject…2017 24 April 2018 1:17-cv-00823 830 Patent Plaintiff District Court, M.D External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Chinese Patent Office
Mallinckrodt
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.